ArticleBritish journal of cancer2025

Survival after neoadjuvant and induction FOLFIRINOX versus gemcitabine-nab-paclitaxel in patients with resected localised pancreatic adenocarcinoma: an international multicentre study.

Thomas F Stoop et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.